Tranzyme Pharma News
Most Popular Tranzyme Pharma Story
Tranzyme Pharma - Biotech IPOs of 2011
Company: Tranzyme Pharma ($TZYM)Based: Durham, NCRaised: $54 million (13.5M shares at $4) Target range: $11 to $13Current price: $3,02 Of the handful of developers that went public in 2011, Tranzyme Read more...
Latest Headlines
- January 17, 2012
- April 4, 2011
- October 20, 2009
- April 22, 2009
- October 14, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
